News
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.
NIH Director Jay Bhattacharya faced sharp questions Tuesday about the agency's proposed 2026 budget from Republican and ...
The NIH has rescinded a policy requiring recipients of new grants to certify they do not have unlawful DEI programs or ...
Today, the AMA tackles AI. Plus: takeaways from the Omada IPO.
WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...
File it under bureaucratic whiplash: On Monday, the National Institutes of Health rescinded a 7-week-old DEI directive, only ...
Health Secretary Robert F. Kennedy Jr. has taken the extraordinary step of firing the expert panel that advises the CDC.
Our nation’s top health official cannot be trusted to protect America’s children and their families,” writes Richard Besser, ...
This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...
Pharmalittle: We’re reading about a Merck shot for RSV, a lawsuit over an Arkansas PBM law, and more
Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...
A bipartisan congressional report alleges that organ procurement organizations use a federal loophole to miscount the number ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results